MedTrace Logo

Meibomian Gland Dysfunction Management

NCT03652337 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-09-05

No results posted yet for this study

Summary

The purpose of this study is to compare electronic debridement of the eyelid margin (BlephEx) to manual debridement of the eyelid margin as treatment options for patients intolerant to contact lens wear consequent to Meibomian gland dysfunction.

Conditions

  • Contact Lens Discomfort
  • Meibomian Gland Dysfunction

Interventions

DEVICE

BlephEx

Electronic lid margin debridement

DEVICE

Manual debridement

Manual lid margin debridement

Sponsors & Collaborators

  • American Academy of Optometry

    collaborator OTHER

  • University of the Incarnate Word

    lead OTHER

Principal Investigators

  • Srihari Narayanan, OD, PhD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-10
Primary Completion
2018-12-01
Completion
2019-04-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03652337 on ClinicalTrials.gov